» Articles » PMID: 25687470

Histone Deacetylase 6 in Health and Disease

Overview
Journal Epigenomics
Specialty Genetics
Date 2015 Feb 18
PMID 25687470
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Histone deacetylase (HDAC)6 is a member of the class IIb HDAC family. This enzyme is zinc-dependent and mainly localized in the cytoplasm. HDAC6 is a unique isoenzyme with two functional catalytic domains and specific physiological roles. Indeed, HDAC6 deacetylates various substrates including α-tubulin and HSP90α, and is involved in protein trafficking and degradation, cell shape and migration. Consequently, deregulation of HDAC6 activity was associated to a variety of diseases including cancer, neurodegenerative diseases and pathological autoimmune response. Therefore, HDAC6 represents an interesting potential therapeutic target. In this review, we discuss structural features of this histone deacetylase, regulation of its expression and activity, biological functions, implication in human disease initiation and progression. Finally will describe novel and selective HDAC6 inhibitors.

Citing Articles

Promising Pharmacological Interventions for Posterior Capsule Opacification: A Review.

Liu Y, Dong X, Wu B, Cheng Z, Zhang J, Wang J Glob Chall. 2024; 8(12):2400181.

PMID: 39679290 PMC: 11637782. DOI: 10.1002/gch2.202400181.


The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?.

Spallotta F, Illi B Biomedicines. 2024; 12(11).

PMID: 39595195 PMC: 11591585. DOI: 10.3390/biomedicines12112631.


HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape.

Gottardi Zamperla M, Illi B, Barbi V, Cencioni C, Santoni D, Gagliardi S Clin Epigenetics. 2024; 16(1):109.

PMID: 39155390 PMC: 11331611. DOI: 10.1186/s13148-024-01725-8.


Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights.

Luan T, Li Q, Huang Z, Feng Y, Xu D, Zhou Y Neurosci Bull. 2024; 40(11):1789-1810.

PMID: 39097850 PMC: 11607281. DOI: 10.1007/s12264-024-01267-2.


Effect of tubastatin A on NLRP3 inflammasome activation in macrophages under hypoxia/reoxygenation conditions.

Li H, Liu C, Cui Y, Chang P, Chong W World J Emerg Med. 2024; 15(4):289-296.

PMID: 39050221 PMC: 11265631. DOI: 10.5847/wjem.j.1920-8642.2024.059.